SCHEDULE 13G/A: FMR LLC and Abigail Johnson Disclose 11.4% Stake in Genpact Ltd
Beneficial Ownership Report
FMR LLC and its Chairman and CEO, Abigail P. Johnson, have jointly disclosed a beneficial ownership of 11.4% in Genpact Ltd's common stock as of December 31, 2024.
Summary
- FMR LLC and Abigail P. Johnson reported a combined beneficial ownership of 20,114,103.89 shares of Genpact Ltd's common stock.
- This stake represents 11.4% of Genpact Ltd's outstanding common stock.
- The filing was made under Rule 13d-1(b), indicating that the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.
- FMR LLC holds sole voting power over 19,545,870.44 shares and sole dispositive power over 20,114,103.89 shares.
- Abigail P. Johnson, as Director, Chairman, and CEO of FMR LLC, is deemed to beneficially own the same aggregate amount of shares (20,114,103.89) due to her controlling interest in FMR LLC.
Sentiment
Score: 5
Explanation: The document is a factual disclosure of beneficial ownership and does not contain information that would inherently convey positive or negative sentiment regarding the issuer's performance or prospects.
Positives
- The disclosure of a significant 11.4% stake by a major institutional investor like FMR LLC can be viewed positively by the market, indicating confidence in Genpact Ltd.
Negatives
- This type of filing does not typically contain negative information about the issuer's performance or outlook.
Risks
- This filing does not detail specific risks related to Genpact Ltd's operations or financial health. It is a disclosure of ownership.
Future Outlook
This Schedule 13G filing does not provide any forward-looking statements or guidance regarding Genpact Ltd's future performance or outlook. It is a historical report of ownership.
Industry Context
This filing reflects a significant passive investment by a large asset management firm, FMR LLC, in Genpact Ltd. Such disclosures are common in the financial industry, where institutional investors regularly report their holdings in public companies. It does not provide specific insights into broader industry trends or competitive dynamics beyond indicating FMR LLC's investment strategy.
Comparison to Industry Standards
- This document is a standard Schedule 13G filing, which is a regulatory requirement for investors acquiring more than 5% of a company's stock.
- The reported 11.4% stake is a substantial institutional holding, which is not uncommon for large asset managers like FMR LLC.
- There are no specific comparable companies or projects mentioned in the document to assess results against.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| NA | NA | NA | NA | The document details Abigail P. Johnson's role as Director, Chairman, and Chief Executive Officer of FMR LLC and her controlling interest in FMR LLC. However, it does not report any changes in the management or key personnel of Genpact Ltd. |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| NA | The document mentions a shareholders' voting agreement among members of the Johnson family regarding their Series B voting common shares of FMR LLC, which impacts the control of FMR LLC. However, it does not disclose any changes in the bylaws, committees, policies, or procedures related to Genpact Ltd's corporate governance. | NA | NA |
Related Party Transactions
- The document describes the relationship between FMR LLC and Abigail P. Johnson, where Abigail P. Johnson, through her family's ownership and a voting agreement, is deemed to form a controlling group with respect to FMR LLC. This clarifies the beneficial ownership structure of the reporting persons but does not disclose related party transactions of Genpact Ltd.
Stakeholder Impact
- Shareholders: The disclosure of a significant 11.4% stake by a prominent institutional investor like FMR LLC could be perceived positively by other shareholders, potentially signaling institutional confidence in Genpact Ltd. It also indicates a large block holder who could exert influence, though the filing states the shares are held in the ordinary course of business and not for control purposes.
- Employees, Customers, Suppliers, Creditors: This filing is unlikely to have a direct or immediate impact on these stakeholders as it pertains solely to an ownership stake and not operational or financial performance.
Key Dates
| Date | Description |
|---|---|
| 2024-12-31 | Date of event which requires filing of this statement (reporting date for beneficial ownership). |
| 2025-02-11 | Date of filing and signature by FMR LLC and Abigail P. Johnson. |
Keywords
Genpact Ltd, FMR LLC, Abigail P. Johnson, Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investor, SEC Filing, Ownership Stake, Investment Management
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.